CLEC10A and amyotrophic lateral sclerosis: Moreover, considering the RNAseq results presented here, where a large cohort of ALS and controls was analyzed, ASRGL1 loss seems to be a more prevalent feature of ALS than HML-2 overexpression, which was found in a subset of ALS patients (20–30%).